Enhabit, Inc. (NYSE:EHAB – Get Free Report) EVP Julie Diane Jolley sold 2,793 shares of the firm’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the sale, the executive vice president owned 139,923 shares in the company, valued at approximately $1,907,150.49. This trade represents a 1.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Enhabit Price Performance
Shares of NYSE EHAB traded up $0.02 during mid-day trading on Wednesday, reaching $13.62. 2,806,514 shares of the company were exchanged, compared to its average volume of 2,568,830. Enhabit, Inc. has a 52 week low of $6.47 and a 52 week high of $13.68. The company’s 50 day moving average price is $11.39 and its 200 day moving average price is $9.49. The stock has a market capitalization of $690.55 million, a PE ratio of -151.28 and a beta of 1.56. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76.
Enhabit (NYSE:EHAB – Get Free Report) last released its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.14. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%.The business had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. Sell-side analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Enhabit
Analyst Ratings Changes
A number of analysts recently weighed in on EHAB shares. TD Cowen restated a “hold” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a research report on Friday, March 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Jefferies Financial Group cut shares of Enhabit from a “buy” rating to a “hold” rating and upped their price objective for the company from $12.50 to $13.80 in a research note on Monday, February 23rd. Oppenheimer cut shares of Enhabit from an “outperform” rating to a “market perform” rating in a research report on Monday, February 23rd. Finally, Truist Financial set a $13.80 price target on shares of Enhabit in a research note on Monday, February 23rd. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $13.57.
View Our Latest Analysis on EHAB
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Articles
- Five stocks we like better than Enhabit
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
